| AMSCs | Adipose-derived mesenchymal stem cells |
| AVN | Avascular necrosis |
| BM-MSCs | Bone marrow mesenchymal stem cells |
| CSD | Critical size defect |
| DMD | Duchenne muscular dystrophy |
| DO | Distraction osteogenesis |
| FGF | Fibroblast growth factor |
| FRI | Functional rating index |
| GDF 5 | Growth differentiation factor 5 |
| GF | Growth factors |
| HA | Hyaluronic acid |
| HGF | Hepatocyte growth factor |
| IA | Intra-articular |
| IGF | Insulin growth factor |
| IL | Interleukin |
| ISCT | International Society for Cell Therapy |
| KOOS | Knee Injury and Osteoarthritis Outcome Score |
| MRI | Magnetic resonance imaging |
| MSCs | Mesenchymal stem cells |
| MSK | Musculoskeletal |
| NPRS | Numeric Pain Rating Scale |
| NSAIDs | Non-steroideal anti-inflammatory drugs |
| OA | Osteoarthritis |
| PRGF | Plasma Rich in Growth Factors |
| PRP | Platelet rich plasma |
| PVF | Peak vertical force |
| RM | Regenerative medicine |
| ROM | Range of movement |
| SDF-1 | Stromal cell derived factor-1 |
| SFDLT | Superficial flexor digitorium longus tendon |
| SVF | Stromal vascular fraction |
| TGF-β | Transformig growth factor β |
| TNF-α | Tumor necrosis factor α |
| VAS | Visual analogue scale |
| VEGF | Vascular endothelial growth factor |
| VI | Vertical impulse |
| WOMAC | Western Ontario and MCMaster Universities Osteoarthritis Index |